更正：超深度下一代测序检测可测量残留病对突变型急性髓系白血病的临床影响
Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in mutated acute myeloid leukemia.
作者信息
Patkar Nikhil, Kodgule Rohan, Kakirde Chinmayee, Raval Goutham, Bhanshe Prasanna, Joshi Swapnali, Chaudhary Shruti, Badrinath Y, Ghoghale Sitaram, Kadechkar Shraddha, Khizer Syed Hasan, Kannan Sadhana, Shetty Dhanalaxmi, Gokarn Anant, Punatkar Sachin, Jain Hasmukh, Bagal Bhausaheb, Menon Hari, Sengar Manju, Khattry Navin, Tembhare Prashant, Subramanian Papagudi, Gujral Sumeet
机构信息
Haematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Homi Bhabha National Institute, Training School Complex, Mumbai, India.
出版信息
Oncotarget. 2019 Jan 15;10(5):617. doi: 10.18632/oncotarget.26610.
Abstract
[This corrects the article DOI: 10.18632/oncotarget.26400.].
摘要
[本文更正了文章DOI：10.18632/oncotarget.26400。]
相似文献
1
Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in mutated acute myeloid leukemia.更正：超深度下一代测序检测可测量残留病对突变型急性髓系白血病的临床影响
Oncotarget. 2019 Jan 15;10(5):617. doi: 10.18632/oncotarget.26610.
2
Minimal/Measurable Residual Disease Monitoring in -Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives.伴有突变的急性髓系白血病中的微小残留病监测：临床观点和展望。
Int J Mol Sci. 2018 Nov 6;19(11):3492. doi: 10.3390/ijms19113492.
3
Sensitive NPM1 Mutation Quantitation in Acute Myeloid Leukemia Using Ultradeep Next-Generation Sequencing in the Diagnostic Laboratory.利用诊断实验室中的超高深度下一代测序技术检测急性髓系白血病中敏感的 NPM1 基因突变定量。
Arch Pathol Lab Med. 2018 May;142(5):606-612. doi: 10.5858/arpa.2017-0229-OA. Epub 2018 Feb 9.
4
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.基于数字液滴 PCR 的移植前 NPM1 突变负担绝对定量可预测急性髓系白血病患者的复发。
Ann Hematol. 2018 Oct;97(10):1757-1765. doi: 10.1007/s00277-018-3373-y. Epub 2018 May 22.
5
Measurable residual disease testing for personalized treatment of acute myeloid leukemia.用于急性髓系白血病个体化治疗的可测量残留病检测
APMIS. 2019 May;127(5):337-351. doi: 10.1111/apm.12926. Epub 2019 Mar 28.
6
Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AML.异基因造血细胞移植后进行深度 NPM1 测序可改善 NPM1 突变型 AML 成人患者的风险评估。
Biol Blood Marrow Transplant. 2018 Aug;24(8):1615-1620. doi: 10.1016/j.bbmt.2018.04.017. Epub 2018 Apr 21.
7
Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.利用下一代测序技术对急性髓系白血病微小残留病进行个体化分析。
Eur J Haematol. 2017 Jan;98(1):26-37. doi: 10.1111/ejh.12780. Epub 2016 Jun 8.
8
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.伴 NPM1 基因突变的急性髓系白血病：诊断、预后和治疗前景。
Curr Opin Oncol. 2009 Nov;21(6):573-81. doi: 10.1097/CCO.0b013e3283313dfa.
9
Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.NPM1 突变型急性髓系白血病中的共存及协同突变
Leuk Res. 2017 May;56:7-12. doi: 10.1016/j.leukres.2017.01.027. Epub 2017 Jan 23.
10
The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.下一代测序在急性髓系白血病和骨髓增生异常综合征诊断及监测中的应用。
Int J Lab Hematol. 2015 May;37 Suppl 1:115-21. doi: 10.1111/ijlh.12361.
Zotero 插件